PET and SPECT Imaging in Hyperkinetic Movement Disorders

No abstract is available for this paper.

• Publication year

  2014

• Venue

  PET and SPECT in Neurology

• Publication date

  2014-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-642-54307-4_32
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder

  2019cited by this paper
• Neuroimaging and neuropathological findings in essential tremor

  2019cited by this paper
• Role of cerebellar GABAergic dysfunctions in the origins of essential tremor

  2019cited by this paper
• Striatal dopaminergic alterations in Tourette’s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies

  2018cited by this paper
• Essential tremor then and now: How views of the most common tremor diathesis have changed over time.

  2018cited by this paper
• Tics and Tourette: a clinical, pathophysiological and etiological review

  2017cited by this paper
• Longitudinal multi-modal neuroimaging in opsoclonus–myoclonus syndrome

  2017cited by this paper
• Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome

  2017cited by this paper
• Pathological ponto-cerebello-thalamo-cortical activations in primary orthostatic tremor during lying and stance

  2017cited by this paper
• Dopamine transporter imaging in essential tremor with and without parkinsonian features

  2015cited by this paper
• Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]‐(+)‐PHNO and [11C]raclopride positron emission tomography imaging study

  2015cited by this paper
• Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor

  2015cited by this paper
• Differences in Regional Glucose Metabolism of the Brain Measured with F-18-FDG-PET in Patients with Essential Tremor According to Their Response to Beta-Blockers

  2015cited by this paper
• Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients

  2012cited by this paper
• The genetics and neuropathology of amyotrophic lateral sclerosis

  2012cited by this paper
• Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment

  2012cited by this paper
• In vivo Mesolimbic D2/3 Receptor Binding Predicts Posttherapeutic Clinical Responses in Restless Legs Syndrome: A Positron Emission Tomography Study

  2012cited by this paper
• Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2012cited by this paper
• Essential tremor is not dependent upon cerebellar Purkinje cell loss.

  2012cited by this paper
• Exome sequencing identifies FUS mutations as a cause of essential tremor.

  2012cited by this paper
• SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease?

  2012cited by this paper
• Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease.

  2011cited by this paper
• Differentiation and diagnosis of tremor.

  2011cited by this paper
• SPECT perfusion patterns distinguish psychogenic from essential tremor.

  2011cited by this paper
• Abnormal metabolic brain networks in Tourette syndrome

  2011cited by this paper
• An overview of human prion diseases

  2011cited by this paper
• Evidence-based guideline update: Treatment of essential tremor

  2011cited by this paper
• Milestones in tremor research

  2011cited by this paper
• Advances in understanding and treatment of Tourette syndrome

  2011cited by this paper
• The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.

  2011cited by this paper
• Classification of movement disorders

  2011cited by this paper
• Milestones in myoclonus

  2011cited by this paper
• Cortical and Non-Cortical Myoclonus of Creutzfeldt-Jakob Disease

  2010cited by this paper
• Availability of brain serotonin transporters in patients with restless legs syndrome

  2010cited by this paper
• Posterior glucose hypometabolism in Lafora disease: Early and late FDG‐PET assessment

  2010cited by this paper
• Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study

  2010cited by this paper
• Single-Photon Emission Computed Tomography in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cited by this paper
• Disappearance of essential tremor after stroke

  2010cited by this paper
• Management of patients with myoclonus: available therapies and the need for an evidence-based approach.

  2010cited by this paper
• Epileptic negative myoclonus: a combined study of EEG and [123I]iomazenil (123I-IMZ) single photon emission computed tomography indicating involvement of medial frontal area.

  2010cited by this paper
• GABAergic Dysfunction in Essential Tremor: An 11C-Flumazenil PET Study

  2010cited by this paper
• Evaluation of Tourette’s syndrome by 99mTc-TRODAT-1 SPECT/CT imaging

  2010cited by this paper
• How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

  2010cited by this paper
• Parasomnias and movement disorders of sleep.

  2009cited by this paper
• Epileptic negative myoclonus: SPECT, PET, and video/EEG studies and the dramatic effects of levetiracetam.

  2009cited by this paper
• Professor Karl-Axel Ekbom and restless legs syndrome.

  2009cited by this paper
• Orthostatic tremor and I123-FP-CIT-SPECT: report of a case

  2009cited by this paper
• Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome

  2009cited by this paper
• Striatal [123I] FP‐CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt–Jakob disease

  2009cited by this paper
• Progression of ataxia in patients with Machado‐Joseph disease

  2009cited by this paper
• Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET

  2008cited by this paper
• [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.

  2008cited by this paper
• Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration.

  2008cited by this paper
• Successful thalamic deep brain stimulation for orthostatic tremor

  2008cited by this paper
• Intact serotonergic and dopaminergic systems in two cases of orthostatic tremor

  2008cited by this paper
• Dopaminergic deficit is not the rule in orthostatic tremor

  2008cited by this paper
• The emerging neuropathology of essential tremor

  2008cited by this paper
• Consensus Statement of the Movement Disorder Society on Tremor

  2008cited by this paper
• Striatal dopamine transporter abnormalities in patients with essential tremor

  2008cited by this paper
• Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome

  2007cited by this paper
• Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.

  2007cited by this paper
• Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome.

  2007cited by this paper
• Clinical, imaging and electrophysiological studies of corticobasal degeneration.

  2007cited by this paper
• Cortical involvement in the generation of essential tremor.

  2007cited by this paper
• Lance-adams syndrome: a report of two cases

  2007cited by this paper
• Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome

  2007cited by this paper
• Substantial Thalamostriatal Dopaminergic Defect in Unverricht‐Lundborg Disease

  2007cited by this paper
• Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging.

  2007cited by this paper
• Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults

  2006cited by this paper
• Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

  2006cited by this paper
• Altered mesolimbocortical and thalamic dopamine in Tourette syndrome

  2006cited by this paper
• Essential tremor associated with pathologic changes in the cerebellum.

  2006cited by this paper
• Neuropathologic findings in essential tremor

  2006cited by this paper
• History of the development of sleep medicine in the United States.

  2005cited by this paper
• The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.

  2005cited by this paper
• Serotonin transporter binding in Tourette Syndrome.

  2005cited by this paper
• Noctural myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration

  2005cited by this paper
• Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome

  2005cited by this paper
• Fatal familial insomnia: a model disease in sleep physiopathology.

  2005cited by this paper
• Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome.

  2005cited by this paper
• The metabolic topography of posthypoxic myoclonus

  2004cited by this paper
• Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP‐CIT/SPECT study

  2004cited by this paper
• Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson's disease.

  2004cited by this paper
• Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep

  2004cited by this paper
• Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?

  2004cited by this paper
• Natural history and syndromic associations of orthostatic tremor: A review of 41 patients

  2004cited by this paper
• [123I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor

  2003cited by this paper
• Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.

  2003cited by this paper
• Clinical Presentations and Phenomenology of Myoclonus

  2003cited by this paper
• Familial and sporadic fatal insomnia.

  2003cited by this paper
• The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates

  2002cited by this paper
• Tc-99m-ECD SPECT brain imaging in children with Tourette's syndrome.

  2002cited by this paper
• SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep

  2002cited by this paper
• Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)

  2002cited by this paper
• No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study

  2001cited by this paper
• Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome

  2001cited by this paper
• A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. 2000.

  2001cited by this paper
• Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.

  2001cited by this paper
• A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism

  2000cited by this paper
• No induction of apoptosis by IFN-β in human antigen-specific T cells

  2000cited by this paper

• No citing papers are available for this paper.